+1 347 708 0418
The MRD (Minimal Residual Disease) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global MRD (Minimal Residual Disease) Testing size is estimated to be xx million in 2021 from USD XX million in 2020, with a change of XX% between 2020 and 2021. The global MRD (Minimal Residual Disease) Testing market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
MRD (Minimal Residual Disease) Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Market segment by Application can be divided into
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions
The key market players for global MRD (Minimal Residual Disease) Testing market are listed below:
ICON plc
ArcherDX(Invitae)
ARUP Laboratories
Asuragen
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
LabCorp
Inivata
Natera
NeoGenomics Laboratories
Opko Health
Quest Diagnostics
Sysmex Corporation
Adaptive Biotechnologies
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe MRD (Minimal Residual Disease) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of MRD (Minimal Residual Disease) Testing, with price, sales, revenue and global market share of MRD (Minimal Residual Disease) Testing from 2019 to 2021.
Chapter 3, the MRD (Minimal Residual Disease) Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MRD (Minimal Residual Disease) Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and MRD (Minimal Residual Disease) Testing market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe MRD (Minimal Residual Disease) Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 MRD (Minimal Residual Disease) Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global MRD (Minimal Residual Disease) Testing Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Flow Cytometry
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Next-Generation Sequencing (NGS)
1.3 Market Analysis by Application
1.3.1 Overview: Global MRD (Minimal Residual Disease) Testing Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Specialty Clinics and Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Institutions
1.4 Global MRD (Minimal Residual Disease) Testing Market Size & Forecast
1.4.1 Global MRD (Minimal Residual Disease) Testing Sales in Value (2016-2026))
1.4.2 Global MRD (Minimal Residual Disease) Testing Sales in Volume (2016-2026)
1.4.3 Global MRD (Minimal Residual Disease) Testing Price by Type (2016-2026) & (US$/Unit)
1.5 Global MRD (Minimal Residual Disease) Testing Production Capacity Analysis
1.5.1 Global MRD (Minimal Residual Disease) Testing Total Production Capacity (2016-2026)
1.5.2 Global MRD (Minimal Residual Disease) Testing Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 MRD (Minimal Residual Disease) Testing Market Drivers
1.6.2 MRD (Minimal Residual Disease) Testing Market Restraints
1.6.3 MRD (Minimal Residual Disease) Testing Trends Analysis
2 Manufacturers Profiles
2.1 ICON plc
2.1.1 ICON plc Details
2.1.2 ICON plc Major Business
2.1.3 ICON plc MRD (Minimal Residual Disease) Testing Product and Services
2.1.4 ICON plc MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 ArcherDX(Invitae)
2.2.1 ArcherDX(Invitae) Details
2.2.2 ArcherDX(Invitae) Major Business
2.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product and Services
2.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 ARUP Laboratories
2.3.1 ARUP Laboratories Details
2.3.2 ARUP Laboratories Major Business
2.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Asuragen
2.4.1 Asuragen Details
2.4.2 Asuragen Major Business
2.4.3 Asuragen MRD (Minimal Residual Disease) Testing Product and Services
2.4.4 Asuragen MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Cergentis B.V.
2.5.1 Cergentis B.V. Details
2.5.2 Cergentis B.V. Major Business
2.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product and Services
2.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Mission Bio
2.7.1 Mission Bio Details
2.7.2 Mission Bio Major Business
2.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Product and Services
2.7.4 Mission Bio MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Guardant Health
2.8.1 Guardant Health Details
2.8.2 Guardant Health Major Business
2.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Product and Services
2.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Invivoscribe
2.9.1 Invivoscribe Details
2.9.2 Invivoscribe Major Business
2.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Product and Services
2.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 LabCorp
2.10.1 LabCorp Details
2.10.2 LabCorp Major Business
2.10.3 LabCorp MRD (Minimal Residual Disease) Testing Product and Services
2.10.4 LabCorp MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Inivata
2.11.1 Inivata Details
2.11.2 Inivata Major Business
2.11.3 Inivata MRD (Minimal Residual Disease) Testing Product and Services
2.11.4 Inivata MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Natera
2.12.1 Natera Details
2.12.2 Natera Major Business
2.12.3 Natera MRD (Minimal Residual Disease) Testing Product and Services
2.12.4 Natera MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 NeoGenomics Laboratories
2.13.1 NeoGenomics Laboratories Details
2.13.2 NeoGenomics Laboratories Major Business
2.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Opko Health
2.14.1 Opko Health Details
2.14.2 Opko Health Major Business
2.14.3 Opko Health MRD (Minimal Residual Disease) Testing Product and Services
2.14.4 Opko Health MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Quest Diagnostics
2.15.1 Quest Diagnostics Details
2.15.2 Quest Diagnostics Major Business
2.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product and Services
2.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Sysmex Corporation
2.16.1 Sysmex Corporation Details
2.16.2 Sysmex Corporation Major Business
2.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product and Services
2.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Adaptive Biotechnologies
2.17.1 Adaptive Biotechnologies Details
2.17.2 Adaptive Biotechnologies Major Business
2.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product and Services
2.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 MRD (Minimal Residual Disease) Testing Sales by Manufacturer
3.1 Global MRD (Minimal Residual Disease) Testing Sales in Volume by Manufacturer (2019-2021e)
3.2 Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in MRD (Minimal Residual Disease) Testing
3.4 Market Concentration Rate
3.4.1 Top 3 MRD (Minimal Residual Disease) Testing Manufacturer Market Share
3.4.2 Top 6 MRD (Minimal Residual Disease) Testing Manufacturer Market Share
3.5 Global MRD (Minimal Residual Disease) Testing Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and MRD (Minimal Residual Disease) Testing Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global MRD (Minimal Residual Disease) Testing Market Size by Region
4.1.1 Global MRD (Minimal Residual Disease) Testing Sales in Volume by Region (2016-2026)
4.1.2 Global MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2026)
4.2 North America MRD (Minimal Residual Disease) Testing Revenue (2016-2026)
4.3 Europe MRD (Minimal Residual Disease) Testing Revenue (2016-2026)
4.4 Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue (2016-2026)
4.5 South America MRD (Minimal Residual Disease) Testing Revenue (2016-2026)
4.6 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue (2016-2026)
5 Market Segment by Type
5.1 Global MRD (Minimal Residual Disease) Testing Sales in Volume by Type (2016-2026)
5.2 Global MRD (Minimal Residual Disease) Testing Revenue by Type (2016-2026)
5.3 Global MRD (Minimal Residual Disease) Testing Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global MRD (Minimal Residual Disease) Testing Sales in Volume by Application (2016-2026)
6.2 Global MRD (Minimal Residual Disease) Testing Revenue by Application (2016-2026)
6.3 Global MRD (Minimal Residual Disease) Testing Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America MRD (Minimal Residual Disease) Testing Sales by Type (2016-2026)
7.2 North America MRD (Minimal Residual Disease) Testing Sales by Application (2016-2026)
7.3 North America MRD (Minimal Residual Disease) Testing Market Size by Country
7.3.1 North America MRD (Minimal Residual Disease) Testing Sales in Volume by Country (2016-2026)
7.3.2 North America MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe MRD (Minimal Residual Disease) Testing Sales by Type (2016-2026)
8.2 Europe MRD (Minimal Residual Disease) Testing Sales by Application (2016-2026)
8.3 Europe MRD (Minimal Residual Disease) Testing Market Size by Country
8.3.1 Europe MRD (Minimal Residual Disease) Testing Sales in Volume by Country (2016-2026)
8.3.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2016-2026)
9.2 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2016-2026)
9.3 Asia-Pacific MRD (Minimal Residual Disease) Testing Market Size by Region
9.3.1 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America MRD (Minimal Residual Disease) Testing Sales by Type (2016-2026)
10.2 South America MRD (Minimal Residual Disease) Testing Sales by Application (2016-2026)
10.3 South America MRD (Minimal Residual Disease) Testing Market Size by Country
10.3.1 South America MRD (Minimal Residual Disease) Testing Sales in Volume by Country (2016-2026)
10.3.2 South America MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type (2016-2026)
11.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application (2016-2026)
11.3 Middle East & Africa MRD (Minimal Residual Disease) Testing Market Size by Country
11.3.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 MRD (Minimal Residual Disease) Testing Typical Distributors
12.3 MRD (Minimal Residual Disease) Testing Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global MRD (Minimal Residual Disease) Testing Revenue by Type, (USD Million), 2021-2026
Table 2. Global MRD (Minimal Residual Disease) Testing Revenue by Application, (USD Million), 2021-2026
Table 3. ICON plc Basic Information, Manufacturing Base and Competitors
Table 4. ICON plc Major Business
Table 5. ICON plc MRD (Minimal Residual Disease) Testing Product and Services
Table 6. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. ArcherDX(Invitae) Basic Information, Manufacturing Base and Competitors
Table 8. ArcherDX(Invitae) Major Business
Table 9. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product and Services
Table 10. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. ARUP Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. ARUP Laboratories Major Business
Table 13. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 14. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Asuragen Basic Information, Manufacturing Base and Competitors
Table 16. Asuragen Major Business
Table 17. Asuragen MRD (Minimal Residual Disease) Testing Product and Services
Table 18. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Cergentis B.V. Basic Information, Manufacturing Base and Competitors
Table 20. Cergentis B.V. Major Business
Table 21. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product and Services
Table 22. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Bio-Rad Laboratories Major Business
Table 25. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 26. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mission Bio Basic Information, Manufacturing Base and Competitors
Table 28. Mission Bio Major Business
Table 29. Mission Bio MRD (Minimal Residual Disease) Testing Product and Services
Table 30. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 32. Guardant Health Major Business
Table 33. Guardant Health MRD (Minimal Residual Disease) Testing Product and Services
Table 34. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Invivoscribe Basic Information, Manufacturing Base and Competitors
Table 36. Invivoscribe Major Business
Table 37. Invivoscribe MRD (Minimal Residual Disease) Testing Product and Services
Table 38. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. LabCorp Basic Information, Manufacturing Base and Competitors
Table 40. LabCorp Major Business
Table 41. LabCorp MRD (Minimal Residual Disease) Testing Product and Services
Table 42. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Inivata Basic Information, Manufacturing Base and Competitors
Table 44. Inivata Major Business
Table 45. Inivata MRD (Minimal Residual Disease) Testing Product and Services
Table 46. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Natera Basic Information, Manufacturing Base and Competitors
Table 48. Natera Major Business
Table 49. Natera MRD (Minimal Residual Disease) Testing Product and Services
Table 50. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. NeoGenomics Laboratories Major Business
Table 53. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 54. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Opko Health Basic Information, Manufacturing Base and Competitors
Table 56. Opko Health Major Business
Table 57. Opko Health MRD (Minimal Residual Disease) Testing Product and Services
Table 58. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 60. Quest Diagnostics Major Business
Table 61. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product and Services
Table 62. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 64. Sysmex Corporation Major Business
Table 65. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product and Services
Table 66. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Adaptive Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 68. Adaptive Biotechnologies Major Business
Table 69. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product and Services
Table 70. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global MRD (Minimal Residual Disease) Testing Sales by Manufacturer (2019-2021e) & (Units)
Table 72. Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in MRD (Minimal Residual Disease) Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global MRD (Minimal Residual Disease) Testing Production Capacity by Company, (Units): 2020 VS 2021
Table 75. Head Office and MRD (Minimal Residual Disease) Testing Production Site of Key Manufacturer
Table 76. MRD (Minimal Residual Disease) Testing New Entrant and Capacity Expansion Plans
Table 77. MRD (Minimal Residual Disease) Testing Mergers & Acquisitions in the Past Five Years
Table 78. Global MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021e) & (Units)
Table 79. Global MRD (Minimal Residual Disease) Testing Sales by Region (2021-2026) & (Units)
Table 80. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021e) & (USD Million)
Table 81. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2021-2026) & (USD Million)
Table 82. Global MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021e) & (Units)
Table 83. Global MRD (Minimal Residual Disease) Testing Sales by Type (2021-2026) & (Units)
Table 84. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2016-2021e) & (USD Million)
Table 85. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2021-2026) & (USD Million)
Table 86. Global MRD (Minimal Residual Disease) Testing Price by Type (2016-2021e) & (US$/Unit)
Table 87. Global MRD (Minimal Residual Disease) Testing Price by Type (2021-2026) & (US$/Unit)
Table 88. Global MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021e) & (Units)
Table 89. Global MRD (Minimal Residual Disease) Testing Sales by Application (2021-2026) & (Units)
Table 90. Global MRD (Minimal Residual Disease) Testing Revenue by Application (2016-2021e) & (USD Million)
Table 91. Global MRD (Minimal Residual Disease) Testing Revenue by Application (2021-2026) & (USD Million)
Table 92. Global MRD (Minimal Residual Disease) Testing Price by Application (2016-2021e) & (US$/Unit)
Table 93. Global MRD (Minimal Residual Disease) Testing Price by Application (2021-2026) & (US$/Unit)
Table 94. North America MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021e) & (Units)
Table 95. North America MRD (Minimal Residual Disease) Testing Sales by Country (2021-2026) & (Units)
Table 96. North America MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021e) & (USD Million)
Table 97. North America MRD (Minimal Residual Disease) Testing Revenue by Country (2021-2026) & (USD Million)
Table 98. North America MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021e) & (Units)
Table 99. North America MRD (Minimal Residual Disease) Testing Sales by Type (2021-2026) & (Units)
Table 100. North America MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021e) & (Units)
Table 101. North America MRD (Minimal Residual Disease) Testing Sales by Application (2021-2026) & (Units)
Table 102. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021e) & (Units)
Table 103. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2021-2026) & (Units)
Table 104. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021e) & (USD Million)
Table 105. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2021-2026) & (USD Million)
Table 106. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021e) & (Units)
Table 107. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2021-2026) & (Units)
Table 108. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021e) & (Units)
Table 109. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2021-2026) & (Units)
Table 110. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021e) & (Units)
Table 111. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2021-2026) & (Units)
Table 112. Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021e) & (USD Million)
Table 113. Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2021-2026) & (USD Million)
Table 114. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021e) & (Units)
Table 115. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2021-2026) & (Units)
Table 116. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021e) & (Units)
Table 117. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2021-2026) & (Units)
Table 118. South America MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021e) & (Units)
Table 119. South America MRD (Minimal Residual Disease) Testing Sales by Country (2021-2026) & (Units)
Table 120. South America MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021e) & (USD Million)
Table 121. South America MRD (Minimal Residual Disease) Testing Revenue by Country (2021-2026) & (USD Million)
Table 122. South America MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021e) & (Units)
Table 123. South America MRD (Minimal Residual Disease) Testing Sales by Type (2021-2026) & (Units)
Table 124. South America MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021e) & (Units)
Table 125. South America MRD (Minimal Residual Disease) Testing Sales by Application (2021-2026) & (Units)
Table 126. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021e) & (Units)
Table 127. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2021-2026) & (Units)
Table 128. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021e) & (USD Million)
Table 129. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2021-2026) & (USD Million)
Table 130. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021e) & (Units)
Table 131. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type (2021-2026) & (Units)
Table 132. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021e) & (Units)
Table 133. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application (2021-2026) & (Units)
Table 134. Direct Channel Pros & Cons
Table 135. Indirect Channel Pros & Cons
Table 136. MRD (Minimal Residual Disease) Testing Typical Distributors
Table 137. MRD (Minimal Residual Disease) Testing Typical Customers
List of Figures
Figure 1. MRD (Minimal Residual Disease) Testing Picture
Figure 2. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 3. Flow Cytometry
Figure 4. Polymerase Chain Reaction (PCR)
Figure 5. Next-Generation Sequencing (NGS)
Figure 6. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 7. Specialty Clinics and Hospitals
Figure 8. Diagnostic Laboratories
Figure 9. Research Institutions
Figure 10. Global MRD (Minimal Residual Disease) Testing Market Size, (USD Million) & (Units): 2020 VS 2021 VS 2026
Figure 11. Global MRD (Minimal Residual Disease) Testing Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global MRD (Minimal Residual Disease) Testing Sales (2016-2026) & (Units)
Figure 13. Global MRD (Minimal Residual Disease) Testing Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global MRD (Minimal Residual Disease) Testing Production Capacity (2016-2026) & (Units)
Figure 15. Global MRD (Minimal Residual Disease) Testing Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. MRD (Minimal Residual Disease) Testing Market Drivers
Figure 17. MRD (Minimal Residual Disease) Testing Market Restraints
Figure 18. MRD (Minimal Residual Disease) Testing Market Trends
Figure 19. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Manufacturer in 2020
Figure 20. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Manufacturer in 2020
Figure 21. MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 MRD (Minimal Residual Disease) Testing Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 MRD (Minimal Residual Disease) Testing Manufacturer (Revenue) Market Share in 2020
Figure 24. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2026)
Figure 25. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2026)
Figure 26. North America MRD (Minimal Residual Disease) Testing Revenue (2016-2026) & (USD Million)
Figure 27. Europe MRD (Minimal Residual Disease) Testing Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue (2016-2026) & (USD Million)
Figure 29. South America MRD (Minimal Residual Disease) Testing Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue (2016-2026) & (USD Million)
Figure 31. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2026)
Figure 32. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2016-2026)
Figure 33. Global MRD (Minimal Residual Disease) Testing Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2026)
Figure 35. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2016-2026)
Figure 36. Global MRD (Minimal Residual Disease) Testing Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2026)
Figure 38. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2026)
Figure 39. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2026)
Figure 40. North America MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2026)
Figure 41. United States MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2026)
Figure 45. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2026)
Figure 46. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2026)
Figure 47. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2026)
Figure 48. Germany MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2026)
Figure 57. China MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2026)
Figure 64. South America MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2026)
Figure 65. South America MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2026)
Figure 66. South America MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2026)
Figure 67. Brazil MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2026)
Figure 73. Turkey MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa MRD (Minimal Residual Disease) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
Buy
